初代細胞培養市場の2030年までの予測：製品、細胞タイプ、分離方法、用途、エンドユーザー、地域別の世界分析

Stratistics MRCによると、世界の初代細胞培養市場は2024年に56億2,000万米ドルを占め、予測期間中にCAGR 15.3％で成長し、2030年には131億9,000万米ドルに達すると予測されています。

初代細胞培養とは、組織や生物から直接細胞を分離し、制御された条件下で試験管内で培養するプロセスを指します。この方法は、細胞の生理的、生化学的、遺伝学的特性のほとんどを保持し、生体内の状態を忠実に模倣した培養を提供します。しかし、一次培養細胞の寿命には限りがあり、通常、分裂回数は有限です。

WHOの予測によると、世界のがん死亡者数は増加の一途をたどり、2030年には1,700万人以上に達するといいます。

成長する製薬・バイオテクノロジー部門

製薬・バイオテクノロジー分野の成長は、革新的で信頼性の高い細胞ベースのモデルに対する需要を煽り、初代細胞培養市場を牽引しています。これらの分野では、不死化細胞株と比較して生理学的により適切なデータを提供するため、創薬、開発、試験のために高品質の初代細胞が必要とされています。個別化医療や再生療法の進歩は、特定の初代細胞の必要性をさらに高めています。さらに、生物製剤やバイオシミラーへの注目が高まっていることから、薬剤の有効性や安全性を評価するために初代細胞の使用が必要となっています。

限られた入手可能性

初代細胞培養市場における利用可能性の制限とは、研究や生産のための初代細胞の調達や入手における課題を指します。初代細胞は組織に直接由来し、寿命が限られているため、希少で高価です。単離プロセスは技術的に難しく、生存可能な細胞は限られた量しか得られない可能性があります。さらに、ドナーのばらつき、倫理的配慮、厳格な規制要件が、その利用可能性をさらに制限しています。

3D細胞培養の進歩

3D細胞培養技術の進歩は、初代細胞培養市場を著しく強化しています。これらの技術は、従来の2D培養に比べ、より生体内環境を模倣することで、より生理学的に適切なモデルを提供します。足場ベースのシステム、スフェロイド、オルガノイドなどの革新は、より正確な細胞-細胞、細胞-マトリックス相互作用を可能にします。これは、疾患モデリング、薬剤スクリーニング、組織工学アプリケーションの改善につながります。さらに、3D培養は、分化状態や機能性を保持した初代細胞の増殖をサポートするため、個別化医療や再生療法にとって貴重なものとなります。

再現性と標準化の問題

初代細胞培養市場では、再現性と標準化が重要な課題です。組織に直接由来する初代細胞は、固有の生物学的変動性を示し、一貫性のない実験結果につながります。標準化の問題は、統一されたプロトコールや品質管理がないために生じ、異なるラボや実験間で一貫性を確保することを難しくしています。このような課題は、研究結果の信頼性を妨げ、細胞ベースのアッセイの開発に影響を与え、規制当局の承認を複雑にする可能性があります。

COVID-19の影響：

COVID-19の大流行は、主にサプライチェーンの混乱と研究室におけるオペレーションの遅延を通じて、初代細胞培養市場に大きな影響を与えました。SARS-CoV-2に関連する研究需要の増加は市場の成長を促し、初代細胞培養はウイルスの挙動研究、ワクチン開発、抗ウイルス薬の試験に不可欠となった。研究所はCOVID-19研究に軸足を移し、細胞培養技術の革新と資金調達が加速しました。しかし、パンデミック関連の研究に注力した結果、COVID-19以外の研究に遅れが生じ、全体的な研究パイプラインとプロジェクトのタイムラインに影響を及ぼしました。

予測期間中、初代細胞分野が最大となる見込み

初代細胞培養市場における初代細胞セグメントの成長は、いくつかの要因に起因しています。医薬品開発や試験のために、より生理学的に関連性の高い細胞モデルに対する需要が高まっているが、初代細胞は組織から直接抽出されるため、これを提供することができます。この分野は、細胞の完全性と機能を維持する分離技術の進歩から利益を得ており、研究および臨床応用における有用性を高めています。さらに1次細胞は、不死化細胞株と比較して、複雑な細胞間相互作用や疾病メカニズムをより正確に研究する能力を研究者に提供します。

酵素分解セグメントは予測期間中最も高いCAGRが見込まれる

初代細胞培養市場における酵素分解とは、細胞培養中に組織から細胞を解離させたり、不要な細胞成分を分解するために酵素を使用するプロセスです。このセグメントの成長を牽引しているのは、効率的で体に優しい細胞分離・維持方法に対する需要の高まりです。トリプシン、コラゲナーゼ、ディスパーゼなどの酵素は、最小限の損傷で高い細胞収率を達成する上で極めて重要であり、それによって研究、医薬品開発、再生医療における様々な応用を支えています。組換え酵素や改良された製剤の開発を含む酵素技術の進歩は、酵素分解法の信頼性と特異性をさらに高めています。

最もシェアの大きい地域：

北米地域は、いくつかの要因により初代細胞培養市場で大きな成長を遂げています。第一に、バイオテクノロジーや製薬分野での研究開発活動が活発化しており、創薬や薬剤開発のための初代細胞培養技術の需要を牽引しています。慢性疾患の増加や個別化医療の必要性から、疾患メカニズムの研究や標的療法の開発における初代細胞培養の重要性が強調されています。さらに、学術機関、研究機関、業界関係者間の共同研究は、知識交換を促進することでこの地域の成長に寄与しています。

CAGRが最も高い地域：

アジア太平洋地域は、いくつかの要因によって初代細胞培養市場が大きく成長しています。中国、インド、日本、韓国などの国々でバイオテクノロジーや製薬産業への投資が増加していることが需要を牽引しています。これらの国々は、研究能力とインフラを拡大し、細胞培養技術に適した環境を育成しています。さらに、慢性疾患の有病率の上昇が医薬品開発における高度な研究の必要性を煽り、市場をさらに押し上げています。

無料のカスタマイズサービス

本レポートをご購読のお客様には、以下の無料カスタマイズオプションのいずれかをご利用いただけます：

• 企業プロファイル
  • 追加市場プレイヤーの包括的プロファイリング（3社まで）
  • 主要企業のSWOT分析（3社まで）
• 地域セグメンテーション
  • 顧客の関心に応じた主要国の市場推計・予測・CAGR（注：フィージビリティチェックによる）
• 競合ベンチマーキング
  • 製品ポートフォリオ、地理的プレゼンス、戦略的提携に基づく主要企業のベンチマーキング

目次

第1章 エグゼクティブサマリー

第2章 序文

• 概要
• ステークホルダー
• 調査範囲
• 調査手法
  • データマイニング
  • データ分析
  • データ検証
  • 調査アプローチ
• 調査情報源
  • 1次調査情報源
  • 2次調査情報源
  • 前提条件

第3章 市場動向分析

• 促進要因
• 抑制要因
• 機会
• 脅威
• 製品分析
• 用途分析
• エンドユーザー分析
• 新興市場
• COVID-19の影響

第4章 ポーターのファイブフォース分析

• 供給企業の交渉力
• 買い手の交渉力
• 代替品の脅威
• 新規参入業者の脅威
• 競争企業間の敵対関係

第5章 世界の初代細胞培養市場：製品別

• 初代細胞
  • 血液細胞
  • 骨細胞
  • 内皮細胞
  • 脂肪細胞
  • 筋細胞
  • 神経細胞
  • 皮膚細胞
  • その他の細胞
• 試薬とサプリメント
  • セラ
  • 成長因子とサイトカイン
  • 緩衝剤と塩
  • アタッチメントソリューション
  • その他の試薬およびサプリメント
• メディア
• その他の製品

第6章 世界の初代細胞培養市場：細胞タイプ別

• ヒト細胞
• 動物細胞

第7章 世界の初代細胞培養市場：分離方法別

• 酵素分解
  • トリプシン
  • プロテアーゼ
  • プロナーゼ
  • パパイン
  • ノイラミニダーゼ
  • ヒアルロニダーゼ
  • エラスターゼ
  • DNアーゼ
  • ディスパーネ
  • コラーゲナーゼ
  • アキュターゼ
  • その他の酵素分解
• 摘出法
• 機械的分離
• その他の分離方法

第8章 世界の初代細胞培養市場：用途別

• ワクチン製造
• ウイルス学
• 細胞・遺伝子治療の開発
• モデルシステム
• 幹細胞療法
• がん調査
• 出生前診断
• その他の用途

第9章 世界の初代細胞培養市場：エンドユーザー別

• 学術研究機関
• 契約研究機関（CRO）
• 製薬・バイオテクノロジー企業
• その他のエンドユーザー

第10章 世界の初代細胞培養市場：地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • イタリア
  • フランス
  • スペイン
  • その他欧州
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • ニュージーランド
  • 韓国
  • その他アジア太平洋
• 南米
  • アルゼンチン
  • ブラジル
  • チリ
  • その他南米
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • カタール
  • 南アフリカ
  • その他中東・アフリカ

第11章 主な発展

• 契約、パートナーシップ、コラボレーション、合弁事業
• 買収と合併
• 新製品発売
• 事業拡大
• その他の主要戦略

第12章 企業プロファイリング

• American Type Culture Collection
• Axol Bioscience Ltd.
• BioIVT
• CGT Global
• Corning Incorporated
• Creative Bioarray
• Cyagen
• Danaher
• Epithelix Sarl
• FUJIFILM Wako Pure Chemical Corporation
• HemaCare Corporation
• Lonza Bioscience
• Mattek
• Merck KGaA
• Neuromics
• PPA Research Group, Inc.
• ReachBio LLC
• STEMCELL Technologies
• Thermo Fisher Scientific Inc.
• XenoTech, LLC

List of Tables

• Table 1 Global Primary Cell Culture Market Outlook, By Region (2022-2030) ($MN)
• Table 2 Global Primary Cell Culture Market Outlook, By Product (2022-2030) ($MN)
• Table 3 Global Primary Cell Culture Market Outlook, By Primary Cells (2022-2030) ($MN)
• Table 4 Global Primary Cell Culture Market Outlook, By Blood Cells (2022-2030) ($MN)
• Table 5 Global Primary Cell Culture Market Outlook, By Bone Cells (2022-2030) ($MN)
• Table 6 Global Primary Cell Culture Market Outlook, By Endothelial Cells (2022-2030) ($MN)
• Table 7 Global Primary Cell Culture Market Outlook, By Fat Cells (2022-2030) ($MN)
• Table 8 Global Primary Cell Culture Market Outlook, By Muscle Cells (2022-2030) ($MN)
• Table 9 Global Primary Cell Culture Market Outlook, By Nerve Cells (2022-2030) ($MN)
• Table 10 Global Primary Cell Culture Market Outlook, By Skin Cells (2022-2030) ($MN)
• Table 11 Global Primary Cell Culture Market Outlook, By Other Cells (2022-2030) ($MN)
• Table 12 Global Primary Cell Culture Market Outlook, By Reagents and Supplements (2022-2030) ($MN)
• Table 13 Global Primary Cell Culture Market Outlook, By Sera (2022-2030) ($MN)
• Table 14 Global Primary Cell Culture Market Outlook, By Growth Factors and Cytokines (2022-2030) ($MN)
• Table 15 Global Primary Cell Culture Market Outlook, By Buffers and Salts (2022-2030) ($MN)
• Table 16 Global Primary Cell Culture Market Outlook, By Attachment Solutions (2022-2030) ($MN)
• Table 17 Global Primary Cell Culture Market Outlook, By Other Reagents and Supplements (2022-2030) ($MN)
• Table 18 Global Primary Cell Culture Market Outlook, By Media (2022-2030) ($MN)
• Table 19 Global Primary Cell Culture Market Outlook, By Other Products (2022-2030) ($MN)
• Table 20 Global Primary Cell Culture Market Outlook, By Cell Type (2022-2030) ($MN)
• Table 21 Global Primary Cell Culture Market Outlook, By Human Cells (2022-2030) ($MN)
• Table 22 Global Primary Cell Culture Market Outlook, By Animal Cells (2022-2030) ($MN)
• Table 23 Global Primary Cell Culture Market Outlook, By Separation Method (2022-2030) ($MN)
• Table 24 Global Primary Cell Culture Market Outlook, By Enzymatic Degradation (2022-2030) ($MN)
• Table 25 Global Primary Cell Culture Market Outlook, By Trypsin (2022-2030) ($MN)
• Table 26 Global Primary Cell Culture Market Outlook, By Protease (2022-2030) ($MN)
• Table 27 Global Primary Cell Culture Market Outlook, By Pronase (2022-2030) ($MN)
• Table 28 Global Primary Cell Culture Market Outlook, By Papain (2022-2030) ($MN)
• Table 29 Global Primary Cell Culture Market Outlook, By Neuraminidase (2022-2030) ($MN)
• Table 30 Global Primary Cell Culture Market Outlook, By Hyaluronidase (2022-2030) ($MN)
• Table 31 Global Primary Cell Culture Market Outlook, By Elastase (2022-2030) ($MN)
• Table 32 Global Primary Cell Culture Market Outlook, By DNase (2022-2030) ($MN)
• Table 33 Global Primary Cell Culture Market Outlook, By Dispane (2022-2030) ($MN)
• Table 34 Global Primary Cell Culture Market Outlook, By Collagenase (2022-2030) ($MN)
• Table 35 Global Primary Cell Culture Market Outlook, By Accutase (2022-2030) ($MN)
• Table 36 Global Primary Cell Culture Market Outlook, By Other Enzymatic Degradations (2022-2030) ($MN)
• Table 37 Global Primary Cell Culture Market Outlook, By Explant Method (2022-2030) ($MN)
• Table 38 Global Primary Cell Culture Market Outlook, By Mechanical Separation (2022-2030) ($MN)
• Table 39 Global Primary Cell Culture Market Outlook, By Other Separation Methods (2022-2030) ($MN)
• Table 40 Global Primary Cell Culture Market Outlook, By Application (2022-2030) ($MN)
• Table 41 Global Primary Cell Culture Market Outlook, By Vaccine Production (2022-2030) ($MN)
• Table 42 Global Primary Cell Culture Market Outlook, By Virology (2022-2030) ($MN)
• Table 43 Global Primary Cell Culture Market Outlook, By Cell & Gene Therapy Development (2022-2030) ($MN)
• Table 44 Global Primary Cell Culture Market Outlook, By Model System (2022-2030) ($MN)
• Table 45 Global Primary Cell Culture Market Outlook, By Stem Cell Therapy (2022-2030) ($MN)
• Table 46 Global Primary Cell Culture Market Outlook, By Cancer Research (2022-2030) ($MN)
• Table 47 Global Primary Cell Culture Market Outlook, By Prenatal Diagnosis (2022-2030) ($MN)
• Table 48 Global Primary Cell Culture Market Outlook, By Other Applications (2022-2030) ($MN)
• Table 49 Global Primary Cell Culture Market Outlook, By End User (2022-2030) ($MN)
• Table 50 Global Primary Cell Culture Market Outlook, By Academic and Research Institutions (2022-2030) ($MN)
• Table 51 Global Primary Cell Culture Market Outlook, By Contract Research Organizations (CROs) (2022-2030) ($MN)
• Table 52 Global Primary Cell Culture Market Outlook, By Pharmaceutical and Biotechnology Companies (2022-2030) ($MN)
• Table 53 Global Primary Cell Culture Market Outlook, By Other End Users (2022-2030) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.

According to Stratistics MRC, the Global Primary Cell Culture Market is accounted for $5.62 billion in 2024 and is expected to reach $13.19 billion by 2030 growing at a CAGR of 15.3% during the forecast period. Primary cell culture refers to the process of isolating cells directly from a tissue or organism and growing them in vitro under controlled conditions. This method provides a culture that closely mimics the in vivo state of the cells, retaining most of their physiological, biochemical, and genetic characteristics. However, primary cultures have a limited lifespan and usually undergo senescence after a finite number of divisions.

According to WHO projections, the number of cancer deaths worldwide will continue to climb and will reach over 17 million by 2030.

Market Dynamics:

Driver:

Growing pharmaceutical and biotech sectors

The growing pharmaceutical and biotech sectors are driving the primary cell culture market by fueling the demand for innovative and reliable cell-based models. These sectors require high-quality primary cells for drug discovery, development, and testing, as they provide more physiologically relevant data compared to immortalized cell lines. Advances in personalized medicine and regenerative therapies further amplify the need for specific primary cells. Additionally, the increasing focus on biologics and biosimilars necessitates the use of primary cells to evaluate drug efficacy and safety.

Restraint:

Limited availability

The limited availability restraint in the Primary Cell Culture Market refers to the challenges in sourcing and obtaining primary cells for research and production. Primary cells are derived directly from tissues and have a finite lifespan, making them scarce and expensive. Isolation processes can be technically demanding and may yield limited quantities of viable cells. Additionally, donor variability, ethical considerations, and stringent regulatory requirements further restrict their availability.

Opportunity:

Advancements in 3D cell culture

Advancements in 3D cell culture technology are significantly enhancing the primary cell culture market. These technologies provide more physiologically relevant models by better mimicking the in vivo environment compared to traditional 2D cultures. Innovations such as scaffold-based systems, spheroids, and organoids allow for more accurate cell-cell and cell-matrix interactions. This leads to improved disease modeling, drug screening, and tissue engineering applications. Moreover, 3D cultures support the growth of primary cells that retain their differentiated state and functionality, making them valuable for personalized medicine and regenerative therapies.

Threat:

Reproducibility and standardization issues

In the primary cell culture market, reproducibility and standardization are critical challenges. Primary cells, derived directly from tissues, exhibit inherent biological variability, leading to inconsistent experimental outcomes. Standardization issues arise due to the lack of uniform protocols and quality controls, making it difficult to ensure consistency across different labs and experiments. Such challenges can hinder the reliability of research findings, affect the development of cell-based assays, and complicate regulatory approvals.

Covid-19 Impact:

The COVID-19 pandemic significantly impacted the primary cell culture market, primarily through disruptions in supply chains and operational delays in laboratories. Increased demand for research related to SARS-CoV-2 spurred growth in the market, as primary cell cultures became crucial for studying virus behavior, developing vaccines, and testing antiviral drugs. Laboratories pivoted to COVID-19 research, which accelerated innovation and funding in cell culture technologies. However, the focus on pandemic-related studies also caused delays in non-COVID-19 research, affecting the overall research pipeline and project timelines.

The primary cells segment is expected to be the largest during the forecast period

The growth of the primary cells segment in the primary cell culture market can be attributed to several factors. There is increasing demand for more physiologically relevant cellular models for drug development and testing, which primary cells provide due to their direct extraction from tissues. This segment benefits from advancements in isolation techniques that preserve cellular integrity and function, enhancing their utility in research and clinical applications. Additionally, primary cells offer researchers the ability to study complex cellular interactions and disease mechanisms more accurately compared to immortalized cell lines.

The enzymatic degradation segment is expected to have the highest CAGR during the forecast period

Enzymatic degradation in the primary cell culture market is the process of using enzymes to dissociate cells from tissues or to degrade unwanted cellular components during cell culture. This segment's growth is driven by the increasing demand for efficient and gentle methods of cell isolation and maintenance. Enzymes such as trypsin, collagenase, and dispase are crucial in achieving high cell yields with minimal damage, thereby supporting various applications in research, drug development, and regenerative medicine. Advancements in enzyme technology, including the development of recombinant enzymes and improved formulations, further enhance the reliability and specificity of enzymatic degradation methods.

Region with largest share:

The North American region has experienced significant growth in the primary cell culture market due to several factors. First, there is increasing research and development activity in the biotechnology and pharmaceutical sectors, driving demand for primary cell culture techniques for drug discovery and development. The rising prevalence of chronic diseases and the need for personalized medicine have emphasized the importance of primary cell cultures in studying disease mechanisms and developing targeted therapies. Moreover, collaborations between academic institutions, research organizations, and industry players have contributed to the region's growth by facilitating knowledge exchange.

Region with highest CAGR:

The Asia-Pacific region has witnessed significant growth in the primary cell culture market due to several factors. Increasing investments in the biotechnology and pharmaceutical industries across countries like China, India, Japan, and South Korea have driven demand. These nations are expanding their research capabilities and infrastructure, fostering a conducive environment for cell culture technologies. Additionally, the rising prevalence of chronic diseases has fuelled the need for advanced research in drug development, further boosting the market.

Key players in the market

Some of the key players in Primary Cell Culture market include American Type Culture Collection, Axol Bioscience Ltd., BioIVT, CGT Global, Corning Incorporated, Creative Bioarray, Cyagen , Danaher, Epithelix Sarl, FUJIFILM Wako Pure Chemical Corporation, HemaCare Corporation, Lonza Bioscience, Mattek, Merck KGaA, Neuromics, PPA Research Group, Inc., ReachBio LLC, STEMCELL Technologies, Thermo Fisher Scientific Inc. and XenoTech, LLC.

Key Developments:

In February 2024, BioIVT announced it has increased its capacity to deliver readily-available fresh, standard and mobilized, human leukopaks. Building on decades of human derived cell collection expertise, this additional capability enables BioIVT to further scale its world-class network of diverse, highly characterized donors and makes the company a leading provider of fresh leukopaks in the UK and mainland Europe.

In June 2024, Danaher Corporation has launched a strategic collaboration with Cincinnati Children's Hospital Medical Center, with the goal of improving patient safety by addressing a leading cause of failure in clinical trials. As part of the Danaher Beacons program, the multi-year collaboration aims to improve liver organoid technology as a drug toxicity screening solution for safeguarding patients.

Products Covered:

• Primary Cells
• Reagents and Supplements
• Media
• Other Products

Cell Types Covered:

• Human Cells
• Animal Cells

Separation Methods Covered:

• Enzymatic Degradation
• Explant Method
• Mechanical Separation
• Other Separation Methods

Applications Covered:

• Vaccine Production
• Virology
• Cell & Gene Therapy Development
• Model System
• Stem Cell Therapy
• Cancer Research
• Prenatal Diagnosis
• Other Applications

End Users Covered:

• Academic and Research Institutions
• Contract Research Organizations (CROs)
• Pharmaceutical and Biotechnology Companies
• Other End Users

Regions Covered:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • Italy
  • France
  • Spain
  • Rest of Europe
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • New Zealand
  • South Korea
  • Rest of Asia Pacific
• South America
  • Argentina
  • Brazil
  • Chile
  • Rest of South America
• Middle East & Africa
  • Saudi Arabia
  • UAE
  • Qatar
  • South Africa
  • Rest of Middle East & Africa

What our report offers:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers Market data for the years 2022, 2023, 2024, 2026, and 2030
• Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

• Company Profiling
  • Comprehensive profiling of additional market players (up to 3)
  • SWOT Analysis of key players (up to 3)
• Regional Segmentation
  • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
  • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

• 2.1 Abstract
• 2.2 Stake Holders
• 2.3 Research Scope
• 2.4 Research Methodology
  • 2.4.1 Data Mining
  • 2.4.2 Data Analysis
  • 2.4.3 Data Validation
  • 2.4.4 Research Approach
• 2.5 Research Sources
  • 2.5.1 Primary Research Sources
  • 2.5.2 Secondary Research Sources
  • 2.5.3 Assumptions

3 Market Trend Analysis

• 3.1 Introduction
• 3.2 Drivers
• 3.3 Restraints
• 3.4 Opportunities
• 3.5 Threats
• 3.6 Product Analysis
• 3.7 Application Analysis
• 3.8 End User Analysis
• 3.9 Emerging Markets
• 3.10 Impact of Covid-19

4 Porters Five Force Analysis

• 4.1 Bargaining power of suppliers
• 4.2 Bargaining power of buyers
• 4.3 Threat of substitutes
• 4.4 Threat of new entrants
• 4.5 Competitive rivalry

5 Global Primary Cell Culture Market, By Product

• 5.1 Introduction
• 5.2 Primary Cells
  • 5.2.1 Blood Cells
  • 5.2.2 Bone Cells
  • 5.2.3 Endothelial Cells
  • 5.2.4 Fat Cells
  • 5.2.5 Muscle Cells
  • 5.2.6 Nerve Cells
  • 5.2.7 Skin Cells
  • 5.2.8 Other Cells
• 5.3 Reagents and Supplements
  • 5.3.1 Sera
  • 5.3.2 Growth Factors and Cytokines
  • 5.3.3 Buffers and Salts
  • 5.3.4 Attachment Solutions
  • 5.3.5 Other Reagents and Supplements
• 5.4 Media
• 5.5 Other Products

6 Global Primary Cell Culture Market, By Cell Type

• 6.1 Introduction
• 6.2 Human Cells
• 6.3 Animal Cells

7 Global Primary Cell Culture Market, By Separation Method

• 7.1 Introduction
• 7.2 Enzymatic Degradation
  • 7.2.1 Trypsin
  • 7.2.2 Protease
  • 7.2.3 Pronase
  • 7.2.4 Papain
  • 7.2.5 Neuraminidase
  • 7.2.6 Hyaluronidase
  • 7.2.7 Elastase
  • 7.2.8 DNase
  • 7.2.9 Dispane
  • 7.2.10 Collagenase
  • 7.2.11 Accutase
  • 7.2.12 Other Enzymatic Degradations
• 7.3 Explant Method
• 7.4 Mechanical Separation
• 7.5 Other Separation Methods

8 Global Primary Cell Culture Market, By Application

• 8.1 Introduction
• 8.2 Vaccine Production
• 8.3 Virology
• 8.4 Cell & Gene Therapy Development
• 8.5 Model System
• 8.6 Stem Cell Therapy
• 8.7 Cancer Research
• 8.8 Prenatal Diagnosis
• 8.9 Other Applications

9 Global Primary Cell Culture Market, By End User

• 9.1 Introduction
• 9.2 Academic and Research Institutions
• 9.3 Contract Research Organizations (CROs)
• 9.4 Pharmaceutical and Biotechnology Companies
• 9.5 Other End Users

10 Global Primary Cell Culture Market, By Geography

• 10.1 Introduction
• 10.2 North America
  • 10.2.1 US
  • 10.2.2 Canada
  • 10.2.3 Mexico
• 10.3 Europe
  • 10.3.1 Germany
  • 10.3.2 UK
  • 10.3.3 Italy
  • 10.3.4 France
  • 10.3.5 Spain
  • 10.3.6 Rest of Europe
• 10.4 Asia Pacific
  • 10.4.1 Japan
  • 10.4.2 China
  • 10.4.3 India
  • 10.4.4 Australia
  • 10.4.5 New Zealand
  • 10.4.6 South Korea
  • 10.4.7 Rest of Asia Pacific
• 10.5 South America
  • 10.5.1 Argentina
  • 10.5.2 Brazil
  • 10.5.3 Chile
  • 10.5.4 Rest of South America
• 10.6 Middle East & Africa
  • 10.6.1 Saudi Arabia
  • 10.6.2 UAE
  • 10.6.3 Qatar
  • 10.6.4 South Africa
  • 10.6.5 Rest of Middle East & Africa

11 Key Developments

• 11.1 Agreements, Partnerships, Collaborations and Joint Ventures
• 11.2 Acquisitions & Mergers
• 11.3 New Product Launch
• 11.4 Expansions
• 11.5 Other Key Strategies

12 Company Profiling

• 12.1 American Type Culture Collection
• 12.2 Axol Bioscience Ltd.
• 12.3 BioIVT
• 12.4 CGT Global
• 12.5 Corning Incorporated
• 12.6 Creative Bioarray
• 12.7 Cyagen
• 12.8 Danaher
• 12.9 Epithelix Sarl
• 12.10 FUJIFILM Wako Pure Chemical Corporation
• 12.11 HemaCare Corporation
• 12.12 Lonza Bioscience
• 12.13 Mattek
• 12.14 Merck KGaA
• 12.15 Neuromics
• 12.16 PPA Research Group, Inc.
• 12.17 ReachBio LLC
• 12.18 STEMCELL Technologies
• 12.19 Thermo Fisher Scientific Inc.
• 12.20 XenoTech, LLC